Last Posted: Aug 27, 2018
- When to Offer Predictive Genetic Testing to Children at Risk of an Inherited Arrhythmia or Cardiomyopathy The Family Perspective
S Christian et al, CIrc Genomics Prec Medicine, August 2018 - Arrhythmogenic Right Ventricular Cardiomyopathy: A Review of Living and Deceased Probands.
Blusztein David I et al. Heart, lung & circulation 2018 Aug - Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals
VD Myers, et al. JAMA Cardiology, August 22, 2018 - Disclosure of diagnosis to at-risk relatives by individuals diagnosed with hypertrophic cardiomyopathy (HCM).
Hudson Janella et al. Journal of community genetics 2018 Aug - Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease.
Prosser Lisa A et al. MDM policy & practice 2018 2018 - Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies.
Asatryan Babken et al. Journal of molecular medicine (Berlin, Germany) 2018 Aug - Clinical Course and Management of Hypertrophic Cardiomyopathy.
Maron Barry J et al. The New England journal of medicine 2018 Aug (7) 655-668 - Biochemical characteristics of newborns with carnitine transporter defect identified by newborn screening in California.
Gallant N M et al. Molecular genetics and metabolism 2017 Nov 122(3) 76-84 - Challenges in the Diagnosis of Anderson-Fabry Disease: A Deceptively Simple and Yet Complicated Genetic Disease.
Marian Ali J et al. Journal of the American College of Cardiology 2016 68(10) 1051-3 - Gene-Based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers.
Nishiuchi Suguru et al. Circulation. Cardiovascular genetics 2017 Dec 10(6)
.png)
No hay comentarios:
Publicar un comentario